Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Virley

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Developing therapeutics for the treatment of multiple sclerosisDavid J Virley
Biochimica Et Biophysica Acta|May 18, 2010
Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseasesJoern E Schroeder, Jill C Richardson, David J Virley
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's diseaseNeil Upton, Tsu Tshen Chuang, Ann J Hunter, et al.
Neuropharmacology|July 7, 2012
Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457Charlotte K Callaghan, Vincent Hok, Andrea Della-Chiesa, et al.
Behavioural Brain Research|December 23, 2011
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognitionKerry A Waters, Tania O Stean, Beverley Hammond, et al.
European Journal of Pharmacology|December 28, 2011
Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampusTomas Ondrejcak, Qinwen Wang, James N C Kew, et al.
Brain Research. Molecular Brain Research|August 28, 2003
An optimistic view for quantifying mRNA in post-mortem human brainPaul Preece, David J Virley, Moheb Costandi, et al.
Journal of Neuroscience Methods|April 22, 2006
Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degenerationLeann P Quinn, Tania O Stean, Helen Chapman, et al.
Brain Research. Molecular Brain Research|March 3, 2004
Amyloid precursor protein mRNA levels in Alzheimer's disease brainPaul Preece, David J Virley, Moheb Costandi, et al.
Brain Research. Molecular Brain Research|August 28, 2003
Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's diseasePaul Preece, David J Virley, Moheb Costandi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Developing therapeutics for the treatment of multiple sclerosisDavid J Virley
Biochimica Et Biophysica Acta|May 18, 2010
Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseasesJoern E Schroeder, Jill C Richardson, David J Virley
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's diseaseNeil Upton, Tsu Tshen Chuang, Ann J Hunter, et al.
Neuropharmacology|July 7, 2012
Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457Charlotte K Callaghan, Vincent Hok, Andrea Della-Chiesa, et al.
Behavioural Brain Research|December 23, 2011
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognitionKerry A Waters, Tania O Stean, Beverley Hammond, et al.
European Journal of Pharmacology|December 28, 2011
Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampusTomas Ondrejcak, Qinwen Wang, James N C Kew, et al.
Brain Research. Molecular Brain Research|August 28, 2003
An optimistic view for quantifying mRNA in post-mortem human brainPaul Preece, David J Virley, Moheb Costandi, et al.
Journal of Neuroscience Methods|April 22, 2006
Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degenerationLeann P Quinn, Tania O Stean, Helen Chapman, et al.
Brain Research. Molecular Brain Research|March 3, 2004
Amyloid precursor protein mRNA levels in Alzheimer's disease brainPaul Preece, David J Virley, Moheb Costandi, et al.
Brain Research. Molecular Brain Research|August 28, 2003
Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's diseasePaul Preece, David J Virley, Moheb Costandi, et al.
Pageof 2